home

RPRX.US | summary | financial summary | prediction chart | global stock news | news graph | compare | components | pairs | earnings

Stock prediction for RPRX.US - Royalty Pharma Plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
symbollastchange%chngnamemcapsectorwiki
RPRX Royalty Pharma plc 22.526B Healthcare wiki y

symbolprev.closerangecharttargetpercentperiodmonthsduerating
 A  RPRX 43.67 0,-0.102,0.194,0.732,-0.102 41.40,38.30,40.17,40.26,40.73,40.96,38.57,41.06,42.45,43.06,42.96,43.27,43.34,42.61,43.40 41.11-48.27 2.34% 267,35,267 7.7 6Jul-30Mar 60.65%

stock prediction graph

prediction values

stocklow targettargethigh targetto go daystarget date
RPRX 41.11 44.69 48.27 2.43% 267 30Mar
RPRX 40.84 43.61 46.38 -0.15% 177 30Dec
RPRX 40.87 43.52 46.16 -0.36% 167 20Dec
RPRX 40.78 43.33 45.88 -0.81% 157 10Dec
RPRX 40.85 43.26 45.68 -0.97% 147 30Nov
RPRX 40.77 43.12 45.48 -1.30% 137 20Nov
RPRX 40.85 43.06 45.28 -1.44% 127 10Nov
RPRX 40.74 42.86 44.97 -1.94% 117 31Oct
RPRX 40.85 42.83 44.81 -2.00% 107 21Oct
RPRX 40.79 42.67 44.54 -2.39% 97 11Oct

``` ```